scholarly journals Review of the Book «Sexual Disorders and Anatomical Problems That Prevent Sexual Intercourse» (Kocharyan G.S.)

Health of Man ◽  
2021 ◽  
pp. 115
Author(s):  
Ihor Gorpynchenko
2016 ◽  
Vol 33 (S1) ◽  
pp. S332-S333
Author(s):  
F. Guermazi ◽  
F. Charfeddine ◽  
K. Mdhaffer ◽  
L. Aribi ◽  
W. Bouattour ◽  
...  

IntroductionWomen with bipolar disorder warrant special consideration with regard to sexual health. The impairment in sexual function would be frequent but underestimated and contributes to non-compliance with treatments.Aims(1) Evaluate sexuality among a population of women affected by bipolar disorder.(2) Determine the factors associated with impaired sexual function.MethodsThis is a cross-sectional and descriptive study during the period ranging from 1st September to 15 October 2015.It was conducted in 40 women suffering from bipolar disorder.The exclusion criteria were: relapse period in sick, age over 60 years or severe somatic comorbidity.The evaluation of sexual function was made using the “Sexual Behavior Questionnaire” (SBQ).ResultsThe mean age was 30 years. Bipolar disorder type I accounted for 72.5%.According to the SBQ, 37.5% of patients had a desire disorder, 57.5% had a frequency less than 3 times per week sexual intercourse, 45% had a drop in excitation and 42.5% were not satisfied with their sex life.Sexual problems are positively correlated at an early age of onset of bipolar disorder (P = 0.001).The lack of desire, the sexual excitation disorder and the decrease in the frequency of sexual intercourse are positively correlated with the depressive phase of bipolar disorder.ConclusionA better understanding of sexual behavior in women with bipolar disorder and the early screening of the sexual disorders must be integrated into the management of the disease. It can improve their quality of life and adherence to therapy.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Author(s):  
Delcea Cristian

Significant delay or absence of orgasm or reduced frequency during sexual intercourse with or without penetration / stimulation and / or after penetration. Markedly reduced intensity of orgasmic sensations and individual psychological discomfort. Women with orgasm disorder have never had a clitoral or vaginal orgasm (penetration) regardless situation or stimulation. Worldwide prevalence of orgasmic disorder in women is 42% and can be maintained depending on partner, stimulation, situation or regardless partner, stimulation, situation etc. The disorder may emerge from the beginning of the sexual life or begin after a period of relatively normal sexual function. Keywords: orgasmic disorder in women, s-on, therapy, testing, evaluation, sexual disorders.


2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Shabani

Introduction:Taking the prevalence of the sexual disorders -which in some studies is reported from 18% to 79% - into account and considering the fact that only a small percentage of the sexual patients refer to the physicians in order to treat their sexual problems. With regard to several problems which the veterans encounter in their personal and social lives, it seems that sexual disorders in these patients and their spouses are widespread.Methodology:In this research performed in the descriptive-temporal method, a questionnaire including all types of sexual disorders in men and women was provided and after standardization by 398 veterans and their spouses.Results:The results of this research are reported as follows; the prevalence of decrease the sexual desire in the veterans is 65/1%, the inability in erection 64/4%, difficulty in erection 60%, disorder in the continuation of erection 85/3%, and premature ejaculation 55%. In addition, the spouses of these veterans are encountered problems like the prevalence of the disorders in sexual desire with the rate of 25/4%, aversion of the sexual intercourse 7%, painfulness within sexual intercourse 8/8%, lack of excitement and vagina drought 10/3%, the disorder in orgasm 14/6%, and the inability in enjoying the sexual intercourse 14/3%.Discussion and conclusion:The high level of prevalence of sexual disorders considered in this research clarifies the necessity and importance of the educational, consultation and the treatment programs for these groups and their spouses.


1970 ◽  
pp. 6
Author(s):  
Lebanese American University

" ... a woman is deprived of her genitals and denied the most basic element of life. Her life becomes one complex on top of another ... Denying a woman the ability to share the pleasure makes her more negative. Denying her relaxation of nerves which accompanies proper sexual intercourse creates in her feelings of great anxiety and loss. In turn, such ... feelings ... give rise to psychological, physical and sexual disorders. An inferiority complex ... apd an awareness that the man is the dominant master, ... gradually cancel her role in society.


Dyspareunia in men refers to a difficult or painful sexual intercourse. Symptoms can be classified as psychogenic, organic, or mixed. It generates mental discomfort and sexual involvement absence up to couple issue. DSM V indexes the disease as „Other specific and non-specific disorders”. Somatic examination of individuals with this disorder doesn’t usually prove genital abnormalities. Repeated experience of genital pain during sexual intercourse may result in the avoidance of sexual experience, breaking existing sexual relationships or limiting the development of new sexual intercourses. Worldwide prevalence of dyspareunia in men is 5%. The disorder may emerge from the beginning of the sexual life or begin after a period of relatively normal sexual function. Keywords: dyspareunia in men, s-on, therapy, testing, evaluation, sexual disorders.


Health of Man ◽  
2021 ◽  
pp. 15-21
Author(s):  
Yurii Gurzhenko

The study investigated the clinical efficacy of the drug Eroton in the treatment of sexual disorders, shows the effect of the study drug on the state of the sexual functions of patients; the degree of patient satisfaction with treatment was assessed; studied the tolerability and possible side effects of the study drug in men in a group of 110 patients. After a course of one month of treatment, all the integrative indicators of ICEF significantly increased in patients. The indicator «erectile function» increased from 12.54±0.87 to 25.12±1.32 (p<0,01), «satisfaction with intercourse» from 7.97±0.40 to 14.63±0.84 (p<0,01), «orgasm» – from 4.52±0.18 to 9.02±0.32 (p<0.01), «general satisfaction» – from 4.03±0.22 up to 8.27±0.46 (p<0,01). The clinical efficacy of the treatment of erectile dysfunction showed «excellent» and «good» results in 92.7 % of patients. When studying the effect of the drug Eroton on the hormonal background in patients, there is a certain tendency to an increase in the content of testosterone in the serum of peripheral blood. This, from our point of view, is due to an improvement in the quality of sex life and an increase in its frequency. The indicator of «sex drive» of the ICEF questionnaire increased by 63.2 %. Improvement of the data on the ejaculatory component of sexual intercourse, which was assessed by the indicator of premature ejaculation in 61 men with this pathology, the clinical effectiveness of the course of treatment was 88.5 %. The time of the refractory period of sexual intercourse in patients decreased, which made it possible to carry out repeated sexual intercourse during the day in 34.5 % at the age of 22 to 34 years, and in 11.8 % of patients aged 22–29 years, 3 sexual intercourses were performed during the day. The frequency of sexual activity in patients with ED increased 2.1–2.4 times, and the quality of life index improved 3.8 times. Patients well tolerated treatment with Eroton. The drug Eroton can be considered as a first-line drug in the treatment of erectile dysfunction.


Sign in / Sign up

Export Citation Format

Share Document